Comparison of hypertension management after stroke and myocardial infarction: Results from ECLAT1 - A French nationwide study

Stroke

Volumn 35, Issue 7, 2004, Pages 1579-1583

  Amar, Jacques ^a,b   Cambou, Jean Pierre ^b   Touzé, Emmanuel ^c   Bongard, Vanina ^b   Jullien, Gérard ^f   Vahanian, Alec ^d   Coppé, Gérard ^e   Mas, Jean Louis ^f  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d BICHAT HOSPITAL   (France)

^e CENTRE HOSPITALIER   (France)

^f INSERM 558 ^*

Author keywords

Hypertension; Secondary prevention; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FRANCE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PULSE PRESSURE; SECONDARY PREVENTION; STROKE; THROMBOSIS;

AGED; ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 3042597829     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000131547.71502.81     Document Type: Article

References (28)

1. Hankey GJ. Stroke: how large a public health problem, and how can the neurologist help? Arch Neurol. 1999;56:748-754.
2. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388-1395.
3. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4:1241-1243.
4. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet. 1999;354:1457-1463.
5. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
6. Gueyffier F, Boissel JP, Boutitie F, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Kerlikowske K, Perry M, Prineas R, Schron E. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke. 1997;28:2557-2562.
7. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305-1315.
8. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
9. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002;33:1656-1659.
10. Bongard V, Cambou JP, Coppe G, Jullien G, Vahanian A, Mas JL. [Prevalence and management of patients with a prior history of atherothrombotic disease in primary care in France. Results of the ECLAT1 survey]. Arch Mal Coeur Vaiss. 2003;96:833-840. In French.
11. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
12. Hajjar I, Kotchen TA, Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
13. Chalmers J, Todd A, Chapman N, Beilin L, Davis S, Donnan G, Frommer M, Huxley R, Lenfant C, MacMahon S, Mancia G, Mendis S, Whitworth J, Zanchetti A; International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens. 2003;21:651-663.
14. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2748.
15. Amar J, Chamontin B, Genes N, Cantet C, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens. 2003;21:1199-1205.
16. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B, PRATIK Study Investigators. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK Study). J Hypertens. 2002;20:779-784.
17. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens. 2002;20:1297-1302.
18. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;162:577-581.
19. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998;32:560-564.
20. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation. 1994;90:762-768.
21. Olsson G, Rehnqvist N, Sjogren A, Erhardt L, Lundman T. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol. 1985;5:1428-1437.
22. Ardissino D, Savonitto S, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup-Mathiesen PM, Marraccini P, Merlini PA, Wahlqvist I, Rehnqvist N; for the IMAGE Study Group. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1995;25:1516-1521.
23. Agence Nationale d'Accréditation et d'Evaluation en Santé. Management of adults with essential hypertension-clinical practice recommendations and economic data. April 2000. The full report (ISBN 2-910653-78-1) is available from Agence Nationale d'Accréditation et d'Evaluation en Santé, Service Communication et Diffusion, 159 rue nationale or can be downloaded free of charge: http://www.anaes.fr or http://www.sante.fr. Accessed May 10, 2004.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
25. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J. Med. 1998;339:1957-1963.
26. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
27. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
28. Rothwell PM, Howard SC, Spence JD. Carotid Endarterectomy Trialists' Collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke. 2003;34:2583-2590.